Valuation: Becton, Dickinson and Company

Market Cap 50B 43.36B 40.71B 37.07B 69.63B 4,772B 70.81B 478B 187B 2,392B 188B 184B 7,975B P/E 2026 *
37.6x
P/E 2027 * 22.1x
Enterprise Value 65.89B 57.13B 53.64B 48.85B 91.74B 6,288B 93.3B 630B 246B 3,152B 247B 242B 10,508B EV / Sales 2026 *
3.42x
EV / Sales 2027 * 3.24x
Free-Float
73.18%
Yield 2026 *
2.16%
Yield 2027 * 2.19%
1 week+2.98%
Current month+9.68%
1 month+16.88%
3 months+28.29%
6 months+6.27%
Current year+19.82%
1 week 151.78
Extreme 151.78
160.06
1 month 131.04
Extreme 131.04
160.06
3 years 111.9
Extreme 111.90117625
208.3
5 years 111.9
Extreme 111.90117625
210.13
10 years 111.9
Extreme 111.90117625
210.13
Manager TitleAgeSince
Chief Executive Officer 53 2020-01-27
Director of Finance/CFO 44 2025-12-04
Compliance Officer - 2023-01-31
Director TitleAgeSince
Director/Board Member 75 2002-09-23
Director/Board Member 71 2010-07-25
Chairman 53 2021-04-27
Change 5-day change 1-year change 3-year change Capi.($)
-0.87%+7.81%+18.25%-22.97% 50B
+0.32%+5.26%-15.07%+5.66% 192B
-0.20%+5.34%-1.63%+8.54% 116B
-1.32%-2.27%+7.21%+65.45% 59.95B
+2.11%+2.55%+34.34%+62.10% 54.64B
-0.88%+6.63%-6.66%-35.54% 50B
+0.75%+10.67%+14.11%-18.09% 34.26B
+0.23%-2.96% - - 31.15B
-1.74%-1.38%+44.29%-12.31% 24.79B
+0.85%+14.53%-3.89%+20.23% 24.07B
Average -0.02%+4.23%+10.11%+8.12% 65.22B
Weighted average by Cap. -0.04%+4.27%+2.14%+9.96%

Financials

2026 *2027 *
Net sales 19.29B 16.73B 15.7B 14.3B 26.86B 1,841B 27.32B 184B 72.06B 923B 72.42B 70.85B 3,077B 19.73B 17.11B 16.06B 14.63B 27.48B 1,883B 27.94B 189B 73.71B 944B 74.08B 72.47B 3,147B
Net income 1.36B 1.18B 1.11B 1.01B 1.9B 130B 1.93B 13.02B 5.09B 65.16B 5.11B 5B 217B 2.16B 1.87B 1.76B 1.6B 3B 206B 3.05B 20.62B 8.06B 103B 8.1B 7.92B 344B
Net Debt 15.88B 13.77B 12.93B 11.78B 22.12B 1,516B 22.49B 152B 59.33B 760B 59.63B 58.34B 2,533B 13.95B 12.1B 11.36B 10.34B 19.43B 1,331B 19.76B 133B 52.11B 667B 52.37B 51.24B 2,225B
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
-
Date Price Change
26-08-13 €157.70 -0.87%
26-08-12 €159.08 +1.20%
26-08-11 €157.20 +1.16%
26-08-10 €155.40 +1.67%
26-08-07 €152.84 -0.20%
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
181.97USD
Average target price
194.42USD
Spread / Average Target
+6.84%

Quarterly revenue - Rate of surprise